General Information of the Compound
Compound ID
CP0526982
Compound Name
3-[[5-(3,4-dichlorophenyl)tetrazol-1-yl]methyl]pyridine
    Show/Hide
Structure
Formula
C13H9Cl2N5
Molecular Weight
306.156
Canonical SMILES
Clc1ccc(cc1Cl)-c1nnnn1Cc1cccnc1
    Show/Hide
InChI
InChI=1S/C13H9Cl2N5/c14-11-4-3-10(6-12(11)15)13-17-18-19-20(13)8-9-2-1-5-16-7-9/h1-7H,8H2
    Show/Hide
InChIKey
OAQDZBNUZRZRDZ-UHFFFAOYSA-N
Physicochemical Property
logP
3.0902
Rotatable Bonds
3
Heavy Atom Count
20
Polar Areas
56.49
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11681068
SID: 16785195
ChEMBL ID
CHEMBL209607
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 = 3981.07 nM
   TI
   LI
   LO
   TS